Series B - Kate Therapeutics - 2024-08-07 - Crunchbase

Kate Therapeutics raised $21775022 on 2024-08-07 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …

CouponFollow Extension

$21775022
OFF

Series B - Kate Therapeutics - 2024-08-07 - Crunchbase

2 days from now

Kate Therapeutics raised $21775022 on 2024-08-07 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …

crunchbase.com

$124
OFF

Kate Therapeutics - Raised $124M Funding From 4 Investors - Tracxn

2 days from now

Oct 4, 2022 · Kate Therapeutics has raised a total funding of $124M over 4 rounds from 4 investors. Investors include Versant Ventures, Osage University Partners and 2 others. Their …

tracxn.com

$124
OFF

Kate Therapeutics - Company Profile - Tracxn

2 days from now

Nov 1, 2024 · Kate Therapeutics - Developer of AAV-based gene therapies to treat genetically defined muscle disease. Raised a total funding of $124M over 4 rounds from 4 investors. ...

tracxn.com

$256
OFF

The Week’s 10 Biggest Funding Rounds: CleanCapital And …

2 days from now

Jun 9, 2023 · Founded in 2016, the company has now raised $256 million, per Crunchbase. 7. (tied) Charm Industrial, $100M, cleantech: San Francisco-based carbon removal technology …

crunchbase.com

$100
OFF

These Are The Industries Where Series B Funding Is Growing Fastest

2 days from now

Nov 29, 2021 · For financial services subsectors, a total of 14 U.S. companies closed Series B rounds of $100 million or more this year. Top Series B recipients included Recharge ($227 …

crunchbase.com

$50
OFF

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

2 days from now

Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

$51000000
OFF

Series A - Kate Therapeutics - 2023-06-08 - Crunchbase

2 days from now

Jun 8, 2023 · Kate Therapeutics raised $51000000 on 2023-06-08 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …

crunchbase.com

$270
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

2 days from now

Apr 28, 2023 · The startup closed a $270 million Series A led by Arch Venture Partners. Orbital is looking to expand RNA-based medicines including next-generation vaccines, …

crunchbase.com

£26
OFF

Series B - Enterprise Therapeutics - 2024-01-29 - Crunchbase

2 days from now

Jan 29, 2024 · life-sciences-europe.com — Enterprise Therapeutics–SEVERAL: investment, 202401 financing round Series B follow-on £26m led by Panakès Partners News • Jan 30, …

crunchbase.com

$100000000
OFF

Series B - Kriya Therapeutics - 2021-07-14 - Crunchbase

2 days from now

Jul 14, 2021 · Kriya Therapeutics raised $100000000 on 2021-07-14 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Business Wire — Kriya …

crunchbase.com

$50000000
OFF

Series B - Jnana Therapeutics - 2021-08-18 - Crunchbase

2 days from now

Aug 18, 2021 · Jnana Therapeutics raised $50000000 on 2021-08-18 in Series B. RA Capital Management RA Capital Management is an investment advisor specializing in the life …

crunchbase.com

$100
OFF

Scribe Therapeutics Closes Series B Round With $100M To Target …

2 days from now

Mar 31, 2021 · Molecular engineering company Scribe Therapeutics has completed an oversubscribed $100 million round of Series B financing to further develop its “CRISPR by …

crunchbase.com

FAQs about Series B - Kate Therapeutics - 2024-08-07 - Crunchbase Coupon?

How many investors does Kate therapeutics have?

Kate Therapeutics has 4 investors including Versant Ventures and UF Innovate Ventures. How much funding has Kate Therapeutics raised to date? Kate Therapeutics has raised When was the last funding round for Kate Therapeutics? Kate Therapeutics closed its last funding round on Aug 7, 2024 from a Series B round. ...

When did Kate Therapeutics close?

Kate Therapeutics closed its last funding round on Aug 7, 2024 from a Series B round. Who are Kate Therapeutics's competitors? Alternatives and possible competitors to Kate Therapeutics may include RubrYc Therapeutics, Geom Therapeutics, and January Therapeutics. Kate Therapeutics is a patient-focused biotechnology company. ...

Where is Kate Therapeutics located?

Kate Therapeutics is located in San Diego, California, United States. Who invested in Kate Therapeutics? Kate Therapeutics has 4 investors including Versant Ventures and UF Innovate Ventures. How much funding has Kate Therapeutics raised to date? Kate Therapeutics has raised When was the last funding round for Kate Therapeutics? ...

What happened to Series B investment in 2022?

Per Crunchbase data, Series B investment in the second half of 2022 was down over 60% from the year-ago period. For a sense of how far things have fallen, we chart out Series B deal counts and funding for the past nine quarters below. Why Series B? So why single out Series B for scrutiny? ...

Who is a series B recipient?

Top Series B recipients included Recharge ($227 million), provider of a subscription payments platform for online brands; Plate IQ ($160 million), a restaurant accounts payable automation platform; and Blockdaemon ($155 million), a blockchain technology company. ...

Are investors backing fewer Series B deals in 2023?

So far in 2023, Crunchbase data shows investors are backing fewer big rounds. There were just six Series B deals of $100 million or more to date this year, an average of fewer than one per week. In 2022, by comparison, there were 90 such rounds, or almost two per week. Still, we are seeing some mega-sized Series B deals this year. ...